Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
Clinical trial NCT05226533 · TERMINATED
Trial details
- NCT number
- NCT05226533
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2022-12-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.